Ax­o­vant: That pos­i­tive p-val­ue we re­port­ed yes­ter­day? Um, we screwed that up too

Yes­ter­day Ax­o­vant ex­ecs watched their stock price $AX­ON col­lapse af­ter the biotech found­ed by the youth­ful for­mer hedge fund man­ag­er Vivek Ra­maswamy was forced to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER